MedTrace Logo

CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes

NCT02030704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-09-11

No results posted yet for this study

Summary

To determine the ability of semi-automated plaque assessment in cardiac computed tomography angiography (CCTA) and high sensitive troponin T (hsTnT) for the risk stratification of patients at intermediate risk for coronary artery disease (CAD).

Conditions

Sponsors & Collaborators

  • Semmelweis University Heart and Vascular Center

    collaborator OTHER

  • Heidelberg University

    collaborator OTHER

  • University Hospital Heidelberg

    lead OTHER

Principal Investigators

  • Grigorios Korosoglou, Prof. Dr. med. · University of Heidelberg, Department of Cardiology, Heidelberg, Germany.

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Germany
  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02030704 on ClinicalTrials.gov